✦ LIBER ✦

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

✍ Scribed by van Nifterik, K A; van den Berg, J; van der Meide, W F; Ameziane, N; Wedekind, L E; Steenbergen, R D M; Leenstra, S; Lafleur, M V M; Slotman, B J; Stalpers, L J A

Book ID: 110000503
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 413 KB
Volume: 103
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605712

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive impact of MGMT promoter methy

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

✍ Guido Reifenberger; Bettina Hentschel; Jörg Felsberg; Gabriele Schackert; Matthi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 569 KB

Can MGMT promoter methylation status be

Can MGMT promoter methylation status be used as a prognostic and predictive marker for glioblastoma multiforme at the present time?

✍ Fietkau, R.; Putz, F.; Lahmer, G.; Semrau, S.; Buslei, R. 📂 Article 📅 2013 🏛 Springer 🌐 German ⚖ 176 KB

Methylation status of the MGMT gene prom

Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin

✍ Chul-Kee Park; Sung-Hye Park; Se-Hoon Lee; Chae-Yong Kim; Dong-Wan Kim; Sun Ha P 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Benefits of interferon-β and temozolomid

Benefits of interferon-β and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter : A multicenter study

✍ Kazuya Motomura; Atsushi Natsume; Yugo Kishida; Hiroyuki Higashi; Yutaka Kondo; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB

## Abstract ## BACKGROUND: The aim of the current study was to catalog genomic and epigenomic abnormalities in newly diagnosed glioblastoma patients and determine the correlation among clinical, genetic, and epigenetic profiles and clinical outcome. ## METHODS: This study retrospectively include

471 MGMT Methylation As a Novel Biomarke

471 MGMT Methylation As a Novel Biomarker for the Identification of Stage III Colorectal Cancers At High-Risk of Disease Recurrence Following Curative Surgery

✍ Mori, Yoshiko; Nagasaka, Takeshi; Tazawa, Hiroshi; Umeda, Yuzo; Morikawa, Tatsuy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Promoter methylation and expression of M

Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas

✍ Jörg Felsberg; Niklas Thon; Sabina Eigenbrod; Bettina Hentschel; Michael C. Sabe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 534 KB

## Abstract Epigenetic silencing of the O^6^‐methylguanine‐DNA methyltransferase (__MGMT__) gene promoter is associated with prolonged survival in glioblastoma patients treated with temozolomide (TMZ). We investigated whether glioblastoma recurrence is associated with changes in the promoter methyl